Page last updated: 2024-08-26

tandospirone and Geographic Atrophy

tandospirone has been researched along with Geographic Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boyer, D; Heier, J; Holz, FG; Jaffe, GJ; Schmidt-Erfurth, U; Schmitz-Valckenberg, S; Staurenghi, G; Wolf-Schnurrbusch, U	1

Trials

1 trial(s) available for tandospirone and Geographic Atrophy

Article	Year
Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study. American journal of ophthalmology, 2015, Volume: 160, Issue:6 Topics: Aged; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Geographic Atrophy; Humans; Isoindoles; Macular Degeneration; Male; Ophthalmic Solutions; Piperazines; Prospective Studies; Pyrimidines; Serotonin Receptor Agonists; Treatment Outcome	2015

Article

Year

Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study.

American journal of ophthalmology, 2015, Volume: 160, Issue:6

Topics: Aged; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Geographic Atrophy; Humans; Isoindoles; Macular Degeneration; Male; Ophthalmic Solutions; Piperazines; Prospective Studies; Pyrimidines; Serotonin Receptor Agonists; Treatment Outcome

2015